9 research outputs found

    Additional file 1: of Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice

    No full text
    Buformin does not upregulate AMPK activation in MMTV-erbB-2 mice. Representative images of p-AMPK immunostained mammary tissues from 18-week-old MMTV-erbB-2 mice that were fed control or buformin diets for 10 weeks are shown. (TIF 789 kb

    Cox proportional hazards model for the development of eGFR <60 ml/min/1.73m<sup>2</sup> after ART initiation among patients with baseline eGFR >90 ml/min/1.73m<sup>2</sup>.

    No full text
    <p>eGFR: estimated glomerular filtration rate, HR: hazard ratios, CI: confidence interval, TMP-SMZ: trimethoprim/sulfamethoxazole, ART: antiretroviral therapy, TDF: tenofovir disoproxil fumarate, NNRTI: non-nucleoside reverse transciptase, LPV/r: lopinavir/ritonavir.</p><p>Adjusted HRs were calculated using multivariable Cox models.</p><p>Cox proportional hazards model for the development of eGFR <60 ml/min/1.73m<sup>2</sup> after ART initiation among patients with baseline eGFR >90 ml/min/1.73m<sup>2</sup>.</p

    Predictors of the baseline eGFR<60 ml/min/1.73m<sup>2</sup>.

    No full text
    <p>eGFR: estimated glomerular filtration rate, OR: odds ratio, CI: confidence interval, IQR: interquartile range, TMP-SMZ: trimethoprim/sulfamethoxazole</p><p>Adjusted ORs were calculated through multivariable analysis using a logistic regression model.</p><p>Predictors of the baseline eGFR<60 ml/min/1.73m<sup>2</sup>.</p

    Characteristics and genotypes of HCV in patients with HIV/HCV co-infection<sup>a</sup>.

    No full text
    <p>Characteristics and genotypes of HCV in patients with HIV/HCV co-infection<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0161844#t001fn002" target="_blank"><sup>a</sup></a>.</p

    Age distribution among different HCV subtypes<sup>a</sup>.

    No full text
    <p>Age distribution among different HCV subtypes<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0161844#t003fn001" target="_blank"><sup>a</sup></a>.</p

    Genotypes distribution in patients with different risk behaviors<sup>a</sup>.

    No full text
    <p>Genotypes distribution in patients with different risk behaviors<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0161844#t004fn002" target="_blank"><sup>a</sup></a>.</p
    corecore